FindTrial
Sign In

Autologous bone marrow derived mesenchymal stem cell therapy for endometrial regeneration in infertilie patients of thin endometrium

Autologous bone marrow derived mesenchymal stem cell therapy for endometrial regeneration in infertilie patients of thin endometrium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17014037
Enrollment
Unknown
Registered
2017-12-19
Start date
2017-12-21
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thin endometrium, intrauterine adhesions

Interventions

BMSCs treatment group:autologous bone marrow derived mesenchymal stem cell intrauterine therapy
control group:transcervical resectionof adhesions

Sponsors

The First Hospital Affiliated to Army Medical University (Southwest Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged between 20-40 years; infertile women of intrauterine adhesions; thin endometrium with the thickness no more than 7mm

Exclusion criteria

Exclusion criteria: Acute pelvic infection; pelvic tuberculosis and/or endometrium tuberculosis; dysfunction of blood coagulation; presence of systemic disease contraindicating pregnancy.

Design outcomes

Primary

MeasureTime frame
intrauterine adhesions;the thickness of endometrium;—

Secondary

MeasureTime frame
biochemical pregnancy rate;clinical pregnancy rate;live birth rate;—

Countries

China

Contacts

Public ContactWei He

The First Hospital Affiliated to Army Medical University (Southwest Hospital)

anyhewei@163.com+86 13608356955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026